International Stem Cell Corporation (OTCBB: ISCO) announced today that
Kenneth Aldrich, Chairman, will be presenting at the 2011 Southern
California Investor Conference on Monday, August 29, 2011 at 1:30 p.m.
Pacific (4:30 p.m. Eastern). The conference takes place at The Island
Hotel in Newport Beach, California.
The Southern California Investor Conference is the only conference
focused exclusively on the wealth of exciting growth companies from
Southern California. The annual one-day conference features more than 35
companies from the region presenting to attendees from throughout the
nation. The conference is open to the public and investors can find a
list of 2011 presenting companies and registration information at www.CaliforniaStocks.com
A webcast of the International Stem Cell Corporation presentation will
be accessible online at http://events.powerstream.net/002/00271/20110829_SCIC_T2/
or from the link on the Company's web site at www.internationalstemcell.com.
An archived version will be available for 30 days.
About International Stem Cell Corporation
International Stem Cell Corporation is focused on the therapeutic
applications of human parthenogenetic stem cells and the development and
commercialization of cell-based research and cosmetic products. ISCO's
core technology, parthenogenesis, results in the creation of pluripotent
human stem cells from unfertilized oocytes (eggs). hpSCs avoid ethical
issues associated with the use or destruction of viable human embryos.
ISCO scientists have created the first parthenogenic, homozygous stem
cell line that can be a source of therapeutic cells with minimal immune
rejection after transplantation into hundreds of millions of individuals
of differing genders, ages and racial background. This offers the
potential to create the first true stem cell bank, UniStemCell™. ISCO
also produces and markets specialized cells and growth media for
therapeutic research worldwide through its subsidiary Lifeline Cell
Technology, and cell-based skin care products through its subsidiary
Lifeline Skin Care. More information is available at www.internationalstemcell.com.
To subscribe to receive ongoing corporate communications, please click
on the following link: http://www.b2i.us/irpass.asp?BzID=1468&to=ea&s=0.
International Stem Cell Corporation
Kenneth
C Aldrich, Chairman
760-940-6383
kaldrich@intlstemcell.com
or
Lippert/Heilshorn
& Associates
Don Markley
310-691-7100
dmarkley@lhai.com